Noa Shafran

474 total citations
7 papers, 243 citations indexed

About

Noa Shafran is a scholar working on Infectious Diseases, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Noa Shafran has authored 7 papers receiving a total of 243 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Epidemiology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Noa Shafran's work include COVID-19 Clinical Research Studies (3 papers), Advanced Breast Cancer Therapies (2 papers) and Respiratory viral infections research (2 papers). Noa Shafran is often cited by papers focused on COVID-19 Clinical Research Studies (3 papers), Advanced Breast Cancer Therapies (2 papers) and Respiratory viral infections research (2 papers). Noa Shafran collaborates with scholars based in Israel, Austria and United States. Noa Shafran's co-authors include Amir Shlomai, Haim Ben‐Zvi, Elad Goldberg, Ella H. Sklan, Inbal Shafran, Liron Sheena, Ilan Krause, Shlomo Almog, Zvi Farfel and H Bank and has published in prestigious journals such as Scientific Reports, Critical Care and BMC Cancer.

In The Last Decade

Noa Shafran

7 papers receiving 239 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Noa Shafran Israel 5 95 60 35 32 28 7 243
Rosanna Carmela De Rosa Italy 5 132 1.4× 51 0.8× 33 0.9× 32 1.0× 20 0.7× 12 237
Simona Iftimie Spain 13 153 1.6× 99 1.6× 35 1.0× 12 0.4× 82 2.9× 38 435
Min Cui China 9 88 0.9× 40 0.7× 19 0.5× 10 0.3× 89 3.2× 20 319
Lorenzo Bertolino Italy 9 205 2.2× 99 1.6× 36 1.0× 35 1.1× 45 1.6× 26 350
Jennifer L. Small-Saunders United States 9 199 2.1× 77 1.3× 22 0.6× 9 0.3× 32 1.1× 12 376
William Knebel United States 11 280 2.9× 161 2.7× 20 0.6× 17 0.5× 28 1.0× 20 504
Ramona Cioboată Romania 11 78 0.8× 69 1.1× 16 0.5× 7 0.2× 47 1.7× 38 330
Maria Gabriella Scarpellini Italy 7 29 0.3× 102 1.7× 24 0.7× 54 1.7× 18 0.6× 9 277
Irene García-García Spain 9 90 0.9× 27 0.5× 13 0.4× 83 2.6× 33 1.2× 20 278
Jiake Tang China 7 221 2.3× 99 1.6× 17 0.5× 14 0.4× 55 2.0× 22 407

Countries citing papers authored by Noa Shafran

Since Specialization
Citations

This map shows the geographic impact of Noa Shafran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noa Shafran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noa Shafran more than expected).

Fields of papers citing papers by Noa Shafran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noa Shafran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noa Shafran. The network helps show where Noa Shafran may publish in the future.

Co-authorship network of co-authors of Noa Shafran

This figure shows the co-authorship network connecting the top 25 collaborators of Noa Shafran. A scholar is included among the top collaborators of Noa Shafran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noa Shafran. Noa Shafran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Shafran, Noa, Alaa Atamna, Ethan Soudry, et al.. (2025). Fatal invasive Apophysomyces variabilis infection in a frequent traveller to Mecca, Saudi Arabia. Journal of Travel Medicine. 32(5). 1 indexed citations
2.
Shafran, Noa, Assaf Issachar, Tzippy Shochat, et al.. (2021). Abnormal liver tests in patients with SARS-CoV-2 or influenza – prognostic similarities and temporal disparities. JHEP Reports. 3(3). 100258–100258. 21 indexed citations
3.
Shafran, Noa, Inbal Shafran, Haim Ben‐Zvi, et al.. (2021). Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients. Scientific Reports. 11(1). 12703–12703. 121 indexed citations
4.
Shlomai, Amir, et al.. (2020). Nasopharyngeal viral load predicts hypoxemia and disease outcome in admitted COVID-19 patients. Critical Care. 24(1). 539–539. 28 indexed citations
5.
Shachar, Shlomit Strulov, Tanya Mashiach, Georgeta Fried, et al.. (2017). Biopsy of breast cancer metastases: patient characteristics and survival. BMC Cancer. 17(1). 7–7. 12 indexed citations
6.
Shachar, Shlomit Strulov, Georgeta Fried, Karen Drumea, Noa Shafran, & Gil Bar‐Sela. (2015). Physicians' Considerations for Repeat Biopsy in Patients With Recurrent Metastatic Breast Cancer. Clinical Breast Cancer. 16(3). e43–e48. 4 indexed citations
7.
Almog, Shlomo, Noa Shafran, Hillel Halkin, et al.. (1985). Mechanism of warfarin potentiation by amiodarone: Dose ? and concentration ? Dependent inhibition of warfarin elimination. European Journal of Clinical Pharmacology. 28(3). 257–261. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026